The molecular mechanism of the anticancer effect of atorvastatin: DNA microarray and bioinformatic analyses

Yan Gao1, Xue-Chun Lu, Hong-Ying Yang

  • 1First Geriatric Cardiology Division, Chinese PLA General Hospital, Beijing 100853, PR China.

Insights

Atorvastatin exhibits anticancer effects by inhibiting cell cycle progression and acting as a histone deacetylase (HDAC) inhibitor. This study reveals its potential as an anticancer drug by altering gene expression in endothelial cells.

Area of Science:

  • Molecular Biology
  • Bioinformatics
  • Pharmacology

Background:

  • Atorvastatin, a statin, is primarily known for its cholesterol-lowering effects.
  • Emerging evidence suggests potential anticancer properties of statins.
  • Understanding the molecular mechanisms underlying these effects is crucial for therapeutic development.

Purpose of the Study:

  • To elucidate the molecular mechanisms and biological pathways responsible for atorvastatin's anticancer effects.
  • To investigate the impact of atorvastatin on endothelial cell gene expression.
  • To identify potential therapeutic targets and applications of atorvastatin in cancer treatment.

Main Methods:

  • Cell-based microarray analysis of human umbilical vein endothelial cells (EA.hy926) treated with atorvastatin.
  • Bioinformatic analyses including Connectivity Map (cMap), Gene Set Enrichment Analysis (GSEA), DAVID pathway analysis, and Gene Ontology (GO) analysis.
  • Validation of differentially expressed genes using real-time polymerase chain reaction (RT-PCR).

Main Results:

  • Atorvastatin treatment (10 µM, 24 h) significantly altered gene expression, upregulating 295 genes and downregulating 354 genes.
  • Kruppel-like factors (KLFs) were upregulated, while cell cycle-related genes (e.g., CCNA2, CCNE2, CCNB1, CCNB2) were downregulated.
  • Gene expression profiles of atorvastatin-treated cells closely resembled those of histone deacetylase (HDAC) inhibitor-treated cells.

Conclusions:

  • Atorvastatin functions as a histone deacetylase (HDAC) inhibitor.
  • It acts as a G1/S and G2/M cell cycle inhibitor, disrupting cell proliferation.
  • These findings support the potential of atorvastatin as an anticancer therapeutic agent.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...